Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

385293

registered interest
date	24/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the total value of projected savings to be made by removing drugs and indications from the Cancer Drugs Fund in England over (1) Q1 of 2015–16, and (2) the whole of 2015–16.
tabling member printed	Lord Hunt of Kings Heath
uin	HL776
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p> </p><p /> <p>NHS England has advised that the projected value of savings from the Cancer Drugs Fund, as a result of removing drugs from the national list, is not yet available.</p><p /> <p> </p><p /> <p> </p><p /> <p> </p><p /> <p>Decisions to de-list drugs were made taking account of the need to ensure the limited resources of the Fund are used most effectively. Advances in medical science mean that new and exciting cancer medicines are emerging all the time and we want people to have access to these too.</p><p /> <p> </p><p /> <p> </p><p /> <p> </p><p /> <p>The Government established the Cancer Drugs Fund to ensure that cancer patients in England have better access to life-extending and improving drugs not routinely funded by the National Health Service.</p><p /> <p> </p><p /> <p> </p><p /> <p> </p><p /> <p>Between October 2010 and March 2015, the Fund has helped over 72,000 cancer patients.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 02/07/2015 15:54:13 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

385294

registered interest
date	24/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer Drugs Fund
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the impact of delisting from the Cancer Drugs Fund on the availability of cancer drugs in the United Kingdom, in comparison with (1) the level of access in 2010 when the Fund was introduced, and (2) availability levels in comparable European countries.
tabling member printed	Lord Hunt of Kings Heath
uin	HL777
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>Neither the Department nor NHS England has made any such assessment.</p><p> </p><p> </p><p> </p><p>Decisions to de-list drugs were made taking account of the need to ensure the limited resources of the Fund are used most effectively. Advances in medical science mean that new and exciting cancer medicines are emerging all the time and we want people to have access to these too.</p><p> </p><p> </p><p> </p><p>The Government established the Cancer Drugs Fund to ensure that cancer patients in England have better access to life-extending and improving drugs not routinely funded by the NHS.</p><p> </p><p> </p><p> </p><p>Between October 2010 and March 2015, the Fund has helped over 72,000 cancer patients.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 02/07/2015 15:55:02 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath